Back to top

LACOG 0419 – NEOSAMBA

  /    /  LACOG 0419 – NEOSAMBA

Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer

Type of Study: Clinical Trial

Sponsor / Support: LACOG / GBECAM

Primary Objectives: Disease-free Survival (DFS) in 5 years

Design: ARM A: AC-T (+/- Carboplatin*); ARM B: T-AC (+/- Carboplatin*)

Sample Size: 494 patients

Principal Investigator: José Bines

Countries LATAM: Brazil